Skip to main content

GLYCOPYRROLATE

NDC 0404-9867 · Henry Schein, Inc.

FDA lists marketing as ended on 2026-08-31.
Generic nameGLYCOPYRROLATE
Dosage formINJECTION
RouteINTRAMUSCULAR, INTRAVENOUS
Active ingredient(s)GLYCOPYRROLATE
Strength.2 mg/mL
Pharmacologic classAnticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
Marketing categoryANDA

Packages

0404-9867-01 — 1 VIAL in 1 BAG (0404-9867-01) / 1 mL in 1 VIAL

Billed under HCPCS

J1596 — Injection, glycopyrrolate, 0.1 mg Medicare Part B payment limit (ASP + 6%): $0.36

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0143-9681 — Glycopyrrolate, 0143-9682 — Glycopyrrolate, 0259-0501 — glycopyrrolate, 0310-4600 — Glycopyrrolate and formoterol fumarate, 0310-4616 — budesonide, glycopyrrolate, and formoterol fumarate, 0310-6616 — budesonide, glycopyrrolate, and formoterol fumarate, 0404-9775 — glycopyrrolate, 0404-9776 — Glycopyrrolate, 0404-9777 — Glycopyrrolate, 0404-9782 — Glycopyrrolate, 0517-4601 — Glycopyrrolate, 0517-4602 — Glycopyrrolate, 0517-4605 — Glycopyrrolate, 0517-4620 — Glycopyrrolate, 0615-8617 — GLYCOPYRROLATE, 0641-6212 — Glycopyrrolate, 0641-6213 — Glycopyrrolate, 0781-3825 — Glycopyrrolate, 0781-3827 — Glycopyrrolate, 0781-3829 — Glycopyrrolate, +177 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.